Clinical Trials Directory

Trials / Sponsors / Instituto Bioclon S.A. de C.V.

Instituto Bioclon S.A. de C.V.

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Trial of Equine F (ab')2 Antivenom for Treatment of Scorpion Envenomation in Morocco
Poisoning by Scorpion Sting
Phase 2 / Phase 32018-07-21
CompletedBlack Widow Spider Antivenin for Patients With Systemic Latrodectism
Latrodectism
Phase 32009-10-01
CompletedPhase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip.
Snake Bite
Phase 32008-05-01
TerminatedStudy to Evaluate the Efficacy of Two Treatment Schemes With Antivipmyn ® for the Treatment of Snake Bite Enve
Snake Bite
Phase 42008-01-01
CompletedThe Efficacy and Safety of Aracmyn in Patients With Systemic Latrodectism
Arachnidism, Latrodectism
Phase 22005-10-01
CompletedOpen Label Study of Alacramyn® in Pediatric Patients With Scorpion Sting Envenomation
Scorpion Sting Envenomation
Phase 32005-05-01
CompletedTreatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Scorpion Sting Envenomation
Phase 2 / Phase 32005-05-01
CompletedA Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab,
Snake Bite, Blood Coagulation Disorders
Phase 22005-01-01
CompletedEstablishment of Natural History of Scorpion Envenomation
Scorpion Sting Envenomation
—2004-08-01
CompletedDouble-Blind, Alacramyn® vs. Placebo in Pediatric Patients
Scorpion Sting Envenomation
Phase 2 / Phase 32004-05-01
CompletedOpen Label Clinical Trial of Anascorp® in Pediatric Patients With Scorpion Sting Envenomation
Scorpion Sting
Phase 32004-04-01